AndroGel, a popular testosterone supplement, has recently been linked to severe cardiac complications including heart attack, stroke, pulmonary embolism, blood clots, and death. In fact, a recent study determined that men who used AndroGel and other testosterone replacement therapies (TRT) were at least twice as likely to have heart attacks within 90 days of beginning treatment compared to men who did not take testosterone.
Free Confidential Lawsuit Evaluation: If you or a loved one suffered a serious injury after using AndroGel, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of AndroGel and we can help.
Update: Jury Rules in Favor of Plaintiff in Retrial, Awards $3 Million to Heart Attack Victim
March 27, 2018 – A jury in Chicago on Monday ordered AbbVie Inc. to pay more than $3 million to a man who had a heart attack after taking AndroGel. While still considered a significant victory for plaintiff Jesse Mitchell, the $3 million is a far cry from the $150 million he was awarded during the first trial in December, which was tossed after U.S. District Judge Matthew Kennelly determined the verdict was “logically incompatible.”
What is AndroGel?
Manufactured by Abbvie (an Abbott Laboratories spinoff), AndroGel is prescribed for replacement therapy in men with testosterone deficiency. AndroGel 1% was approved by the FDA in 2000, and 1.62% strength was approved in 2011. The product is made as a gel for topical use, and is currently the best-selling testosterone booster on the U.S. market today.
Side Effects of AndroGel
Despite its success and widespread usage, AndroGel has been linked to the following serious side effects:
First AndroGel Bellwether Ends in Mistrial
June 19, 2017 – The first attempt to hold AbbVie Inc. responsible for the side effects alleged from AndroGel has ended in a mistrial after the lead plaintiff’s attorney suffered from heart problems. Court documents indicate that the man was hospitalized with heart complications on June 10 and underwent an unspecified procedure, but has since been released and is now recovering back home.
AndroGel Heart Attack Risk Linked to Calcium, Study Finds
May 5, 2016 – Amid concerns that testosterone supplements like AndroGel could increase the risk of heart attack, a new study suggests that the products may cause calcium buildup in the blood, leading to artery blockages and severe cardiovascular side effects. Calcification leads to narrowing and hardening of the blood vessel, which makes the heart work harder to perform its duties. It can also cause problems with the heart valves. These issues can increase the risk of heart attack and other cardiovascular complications, according to the study.
How can an attorney help me if a loved one was injured or died after taking AndroGel?
Many of those who have been injured by AndroGel side effects are now filing lawsuits to recover compensation for their damages. However, those who have died after using AndroGel can no longer bring a claim against the manufacturer. For this reason, those who have died after undergoing testosterone replacement therapy need their spouses, family members, and heirs to fight for them and hold those responsible for the death.
Is There a Class Action?
No class action lawsuit has yet been filed in the AndroGel litigation. However, in March 2014 a motion was filed to consolidate all federal lawsuits alleging injuries from AndroGel into a multidistrict litigation (MDL) for pretrial handling. However, since nearly identical complaints have been filed against the makers of Axiron, Testim, AndroDerm and other testosterone products, the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided to centralize the entire litigation before U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois.
While it is common for such litigation to be referred to as a class action, each individual claim in the MDL will remain its own separate and distinct case. Since each plaintiff’s alleged injury will have different consequences, the litigation cannot proceed through a single class representative. Each plaintiff will still have to prove that their injury was caused by a testosterone supplement, and that the manufacturer of the product failed to adequately warn of the potential health risks.
As part of the MDL, 2 groups of cases are being prepared for early trial dates, known as “bellwether trials.” The first involves claims filed over Androgel, which will result in a series of 6 trials scheduled to begin about one-per-month between October 2016 and April 2017. Trials involving the 2nd bellwether group, for complaints over other testosterone boosters, are not expected to begin until late 2017.
Judge Selects 8 Bellwether Trials in Testosterone Litigation
September 2, 2016 – U.S. District Judge Matthew Kennelly has selected 8 lawsuits to move forward as bellwether trials in the testosterone multidistrict litigation (MDL 2545) in Illinois. All 8 suits designated as bellwether trials involve injuries alleged from AndroGel. Four allege claims of myocardial infarction or stroke, and the other 4 involve venous thromboembolism (VTE).
Do I have an AndroGel Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in AndroGel Lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.
Free Confidential Case Evaluation: Again, if you’ve been injured by AndroGel side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and we can help.